Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Report Summary

GlobalData’s new report, “Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Genetic Testing market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within three market categories – Inborn Gene or Chromosome Alterations, Other Genetic Tests and Acquired Gene or Chromosome Alterations. The report also provides company shares and distribution shares data for the overall Genetic Testing market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Scope

• Market size data for Genetic Testing market categories – Inborn Gene or Chromosome Alterations, Other Genetic Tests and Acquired Gene or Chromosome Alterations.
• Annualized market revenues ($m) data for each of the segments and sub-segments within the three market categories. Data from 2003 to 2010, forecast forward for seven years to 2017.
• 2010 company shares and distribution shares data for the overall Genetic Testing market in each of the aforementioned countries.
• Global corporate-level profiles of key companies operating within the Genetic Testing market in BRICS.
• Key players covered include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthcare, Qiagen N.V., Bio-Rad Laboratories, Inc. and Gen-Probe Incorporated.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Genetic Testing competitive landscape in BRICS.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8

2 Introduction 10
2.1 What is This Report About? 10

3 Genetic Testing in BRICS 11
3.1 Genetic Testing, BRICS, Overall Revenue ($m), 2003-2017 11
3.2 Genetic Testing, BRICS, Company share (2009-2010) 17

4 Genetic Testing In Brazil 19
4.1 Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 19
4.2 Inborn Gene or Chromosome Alterations In Brazil 25
4.2.1 Inborn Gene or Chromosome Alterations, Brazil, Overall Revenue (2003-2017) 25
4.3 Other Genetic Tests In Brazil 27
4.3.1 Other Genetic Tests, Brazil, Overall Revenue (2003-2017) 27
4.4 Acquired Gene or Chromosome Alterations In Brazil 29
4.4.1 Acquired Gene or Chromosome Alterations, Brazil, Overall Revenue (2003-2017) 29
4.5 Genetic Testing, Brazil, Distribution Share (2009-2010) 31
4.6 Genetic Testing, Brazil, Company Share (2009-2010) 32

5 Genetic Testing In Russian Federation 34
5.1 Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 34
5.2 Inborn Gene or Chromosome Alterations in Russian Federation 40
5.2.1 Inborn Gene or Chromosome Alterations, Russian Federation, Overall Revenue (2003-2017) 40
5.3 Other Genetic Tests In Russian Federation 42
5.3.1 Other Genetic Tests, Russian Federation, Overall Revenue (2003-2017) 42
5.4 Acquired Gene or Chromosome Alterations In Russian Federation 44
5.4.1 Acquired Gene or Chromosome Alterations, Russian Federation, Overall Revenue (2003-2017) 44
5.5 Genetic Testing, Russian Federation, Distribution Share (2009-2010) 47
5.6 Genetic Testing, Russian Federation, Company Share (2009-2010) 48

6 Genetic Testing In India 50
6.1 Genetic Testing, India, Overall Revenue ($m), USD Actual, 2003-2017 50
6.2 Inborn Gene or Chromosome Alterations in India 56
6.2.1 Inborn Gene or Chromosome Alterations, India, Overall Revenue (2003-2017) 56
6.3 Other Genetic Tests In India 58
6.3.1 Other Genetic Tests, India, Overall Revenue (2003-2017) 58
6.4 Acquired Gene or Chromosome Alterations In India 60
6.4.1 Acquired Gene or Chromosome Alterations, India, Overall Revenue (2003-2017) 60
6.5 Genetic Testing, India, Distribution Share (2009-2010) 62
6.6 Genetic Testing, India, Company Share (2009-2010) 63

7 Genetic Testing In China 65
7.1 Genetic Testing, China, Overall Revenue ($m), USD Actual, 2003-2017 65
7.2 Inborn Gene or Chromosome Alterations In China 71
7.2.1 Inborn Gene or Chromosome Alterations, China, Overall Revenue (2003-2017) 71
7.3 Other Genetic Tests In China 73
7.3.1 Other Genetic Tests, China, Overall Revenue (2003-2017) 73
7.4 Acquired Gene or Chromosome Alterations In China 75
7.4.1 Acquired Gene or Chromosome Alterations, China, Overall Revenue (2003-2017) 75
7.5 Genetic Testing, China, Distribution Share (2009-2010) 77
7.6 Genetic Testing, China, Company Share (2009-2010) 78

8 Genetic Testing In South Africa 80
8.1 Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 80
8.2 Inborn Gene or Chromosome Alterations In South Africa 86
8.2.1 Inborn Gene or Chromosome Alterations, South Africa, Overall Revenue (2003-2017) 86
8.3 Other Genetic Tests In South Africa 88
8.3.1 Other Genetic Tests, South Africa, Overall Revenue (2003-2017) 88
8.4 Acquired Gene or Chromosome Alterations In South Africa 90
8.4.1 Acquired Gene or Chromosome Alterations, South Africa, Overall Revenue (2003-2017) 90
8.5 Genetic Testing, South Africa, Distribution Share (2009-2010) 92
8.6 Genetic Testing, South Africa, Company Share (2009-2010) 93

9 Overview of Key Companies in BRICS Genetic Testing Market 95
9.1 F. Hoffmann-La Roche Ltd. 95
9.1.1 Company Overview 95
9.1.2 Share in the BRICS Genetic Testing Market 96
9.2 Abbott Laboratories 97
9.2.1 Company Overview 97
9.2.2 Share in the BRICS Genetic Testing Market 98
9.3 Siemens Healthcare 99
9.3.1 Company Overview 99
9.3.2 Share in the BRICS Genetic Testing Market 100
9.4 Qiagen N.V. 101
9.4.1 Company Overview 101
9.4.2 Share in the BRICS Genetic Testing Market 102
9.5 Bio-Rad Laboratories, Inc. 103
9.5.1 Company Overview 103
9.5.2 Share in the BRICS Genetic Testing Market 104
9.6 Gen-Probe Incorporated 105
9.6.1 Company Overview 105
9.6.2 Share in the BRICS Genetic Testing Market 106

10 Appendix 107
10.1 Definitions of Markets Covered in the Report 108
10.1.1 Genetic Testing 108
10.2 Research Methodology 109
10.3 Secondary Research 109
10.4 Primary Research 110
10.5 Models 110
10.6 Forecasts 111
10.7 Expert Panels 111
10.8 GlobalData Consulting 111
10.9 Currency Conversion 112
10.10 Contact Us 112
10.11 Disclaimer 112

List of Tables

Table 1: Genetic Testing, BRICS, Overall Revenue ($m), 2003-2017 12
Table 2: Genetic Testing, BRICS, Overall Revenue ($m), Historic, 2003-2010 14
Table 3: Genetic Testing, BRICS, Overall Revenue ($m), Forecast, 2010-2017 16
Table 4: Genetic Testing, BRICS, Company share by Revenue ($m), USD Actual, 2009-2010 18
Table 5: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 20
Table 6: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 22
Table 7: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 24
Table 8: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), Historic, 2003-2010 25
Table 9: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), Forecast, 2010-2017 26
Table 10: Other Genetic Tests, Brazil, Revenue ($m), Historic, 2003-2010 27
Table 11: Other Genetic Tests, Brazil, Revenue ($m), Forecast, 2010-2017 28
Table 12: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), Historic, 2003-2010 29
Table 13: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), Forecast, 2010-2017 30
Table 14: Genetic Testing, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 31
Table 15: Genetic Testing, Brazil, Company share by Revenue ($m), USD Actual, 2009-2010 33
Table 16: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 35
Table 17: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 37
Table 18: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 39
Table 19: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Historic, 2003-2010 40
Table 20: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Forecast, 2010-2017 41
Table 21: Other Genetic Tests, Russian Federation, Revenue ($m), Historic, 2003-2010 42
Table 22: Other Genetic Tests, Russian Federation, Revenue ($m), Forecast, 2010-2017 43
Table 23: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Historic, 2003-2010 45
Table 24: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Forecast, 2010-2017 46
Table 25: Genetic Testing, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 47
Table 26: Genetic Testing, Russian Federation, Company share by Revenue ($m), USD Actual, 2009-2010 49
Table 27: Genetic Testing, India, Overall Revenue ($m), USD Actual, 2003-2017 51
Table 28: Genetic Testing, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 53
Table 29: Genetic Testing, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 55
Table 30: Inborn Gene or Chromosome Alterations, India, Revenue ($m), Historic, 2003-2010 56
Table 31: Inborn Gene or Chromosome Alterations, India, Revenue ($m), Forecast, 2010-2017 57
Table 32: Other Genetic Tests, India, Revenue ($m), Historic, 2003-2010 58
Table 33: Other Genetic Tests, India, Revenue ($m), Forecast, 2010-2017 59
Table 34: Acquired Gene or Chromosome Alterations, India, Revenue ($m), Historic, 2003-2010 60
Table 35: Acquired Gene or Chromosome Alterations, India, Revenue ($m), Forecast, 2010-2017 61
Table 36: Genetic Testing, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 62
Table 37: Genetic Testing, India, Company share by Revenue ($m), USD Actual, 2009-2010 64
Table 38: Genetic Testing, China, Overall Revenue ($m), USD Actual, 2003-2017 66
Table 39: Genetic Testing, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 68
Table 40: Genetic Testing, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 70
Table 41: Inborn Gene or Chromosome Alterations, China, Revenue ($m), Historic, 2003-2010 71
Table 42: Inborn Gene or Chromosome Alterations, China, Revenue ($m), Forecast, 2010-2017 72
Table 43: Other Genetic Tests, China, Revenue ($m), Historic, 2003-2010 73
Table 44: Other Genetic Tests, China, Revenue ($m), Forecast, 2010-2017 74
Table 45: Acquired Gene or Chromosome Alterations, China, Revenue ($m), Historic, 2003-2010 75
Table 46: Acquired Gene or Chromosome Alterations, China, Revenue ($m), Forecast, 2010-2017 76
Table 47: Genetic Testing, China, Distribution Share by Revenue ($m), USD Actual, 2009-2010 77
Table 48: Genetic Testing, China, Company share by Revenue ($m), USD Actual, 2009-2010 79
Table 49: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 81
Table 50: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 83
Table 51: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 85
Table 52: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), Historic, 2003-2010 86
Table 53: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), Forecast, 2010-2017 87
Table 54: Other Genetic Tests, South Africa, Revenue ($m), Historic, 2003-2010 88
Table 55: Other Genetic Tests, South Africa, Revenue ($m), Forecast, 2010-2017 89
Table 56: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), Historic, 2003-2010 90
Table 57: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), Forecast, 2010-2017 91
Table 58: Genetic Testing, South Africa, Distribution Share by Revenue ($m), USD Actual, 2009-2010 92
Table 59: Genetic Testing, South Africa, Company share by Revenue ($m), USD Actual, 2009-2010 94
Table 60: F. Hoffmann-La Roche Ltd., Revenue ($m), BRICS Genetic Testing Market, 2010 96
Table 61: Abbott Laboratories, Revenue ($m), BRICS Genetic Testing Market, 2010 98
Table 62: Siemens Healthcare, Revenue ($m), BRICS Genetic Testing Market, 2010 100
Table 63: Qiagen N.V., Revenue ($m), BRICS Genetic Testing Market, 2010 102
Table 64: Bio-Rad Laboratories, Inc., Revenue ($m), BRICS Genetic Testing Market, 2010 104
Table 65: Gen-Probe Incorporated, Revenue ($m), BRICS Genetic Testing Market, 2010 106
Table 66: USD to Local Currency, BRICS, Average Exchange Rate, 2003-2010 112

List of Figures

Figure 1: Genetic Testing, BRICS, Overall Revenue ($m), 2003-2017 11
Figure 2: Genetic Testing, BRICS, Overall Revenue ($m), Historic, 2003-2010 13
Figure 3: Genetic Testing, BRICS, Overall Revenue ($m), Forecast, 2010-2017 15
Figure 4: Genetic Testing, BRICS, Company share (%), 2010 17
Figure 5: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 19
Figure 6: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 21
Figure 7: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 23
Figure 8: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), Historic, 2003-2010 25
Figure 9: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), Forecast, 2010-2017 26
Figure 10: Other Genetic Tests, Brazil, Revenue ($m), Historic, 2003-2010 27
Figure 11: Other Genetic Tests, Brazil, Revenue ($m), Forecast, 2010-2017 28
Figure 12: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), Historic, 2003-2010 29
Figure 13: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), Forecast, 2010-2017 30
Figure 14: Genetic Testing, Brazil, Company share (%), 2010 32
Figure 15: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 34
Figure 16: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 36
Figure 17: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 38
Figure 18: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Historic, 2003-2010 40
Figure 19: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Forecast, 2010-2017 41
Figure 20: Other Genetic Tests, Russian Federation, Revenue ($m), Historic, 2003-2010 42
Figure 21: Other Genetic Tests, Russian Federation, Revenue ($m), Forecast, 2010-2017 43
Figure 22: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Historic, 2003-2010 44
Figure 23: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Forecast, 2010-2017 46
Figure 24: Genetic Testing, Russian Federation, Company share (%), 2010 48
Figure 25: Genetic Testing, India, Overall Revenue ($m), USD Actual, 2003-2017 50
Figure 26: Genetic Testing, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 52
Figure 27: Genetic Testing, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 54
Figure 28: Inborn Gene or Chromosome Alterations, India, Revenue ($m), Historic, 2003-2010 56
Figure 29: Inborn Gene or Chromosome Alterations, India, Revenue ($m), Forecast, 2010-2017 57
Figure 30: Other Genetic Tests, India, Revenue ($m), Historic, 2003-2010 58
Figure 31: Other Genetic Tests, India, Revenue ($m), Forecast, 2010-2017 59
Figure 32: Acquired Gene or Chromosome Alterations, India, Revenue ($m), Historic, 2003-2010 60
Figure 33: Acquired Gene or Chromosome Alterations, India, Revenue ($m), Forecast, 2010-2017 61
Figure 34: Genetic Testing, India, Company share (%), 2010 63
Figure 35: Genetic Testing, China, Overall Revenue ($m), USD Actual, 2003-2017 65
Figure 36: Genetic Testing, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 67
Figure 37: Genetic Testing, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 69
Figure 38: Inborn Gene or Chromosome Alterations, China, Revenue ($m), Historic, 2003-2010 71
Figure 39: Inborn Gene or Chromosome Alterations, China, Revenue ($m), Forecast, 2010-2017 72
Figure 40: Other Genetic Tests, China, Revenue ($m), Historic, 2003-2010 73
Figure 41: Other Genetic Tests, China, Revenue ($m), Forecast, 2010-2017 74
Figure 42: Acquired Gene or Chromosome Alterations, China, Revenue ($m), Historic, 2003-2010 75
Figure 43: Acquired Gene or Chromosome Alterations, China, Revenue ($m), Forecast, 2010-2017 76
Figure 44: Genetic Testing, China, Company share (%), 2010 78
Figure 45: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 80
Figure 46: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 82
Figure 47: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 84
Figure 48: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), Historic, 2003-2010 86
Figure 49: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), Forecast, 2010-2017 87
Figure 50: Other Genetic Tests, South Africa, Revenue ($m), Historic, 2003-2010 88
Figure 51: Other Genetic Tests, South Africa, Revenue ($m), Forecast, 2010-2017 89
Figure 52: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), Historic, 2003-2010 90
Figure 53: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), Forecast, 2010-2017 91
Figure 54: Genetic Testing, South Africa, Company share (%), 2010 93
Figure 55: F. Hoffmann-La Roche Ltd., Company Share (%), BRICS Genetic Testing Market, 2010 96
Figure 56: Abbott Laboratories, Company Share (%), BRICS Genetic Testing Market, 2010 98
Figure 57: Siemens Healthcare, Company Share (%), BRICS Genetic Testing Market, 2010 100
Figure 58: Qiagen N.V., Company Share (%), BRICS Genetic Testing Market, 2010 102
Figure 59: Bio-Rad Laboratories, Inc., Company Share (%), BRICS Genetic Testing Market, 2010 104
Figure 60: Gen-Probe Incorporated, Company Share (%), BRICS Genetic Testing Market, 2010 106